CEFTAZIDIME Drug Patent Profile
✉ Email this page to a colleague
When do Ceftazidime patents expire, and when can generic versions of Ceftazidime launch?
Ceftazidime is a drug marketed by Acs Dobfar, Aurobindo Pharma Ltd, Wockhardt, B Braun, and Baxter Hlthcare. and is included in six NDAs.
The generic ingredient in CEFTAZIDIME is ceftazidime sodium. There are seventeen drug master file entries for this compound. Additional details are available on the ceftazidime sodium profile page.
Summary for CEFTAZIDIME
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 42 |
| Clinical Trials: | 67 |
| Patent Applications: | 7,279 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | CEFTAZIDIME at DailyMed |
Recent Clinical Trials for CEFTAZIDIME
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Qianfoshan Hospital | N/A |
| Arrevus Inc. | Phase 2 |
| King Faisal Specialist Hospital & Research Center | Phase 3 |
Pharmacology for CEFTAZIDIME
| Drug Class | Cephalosporin Antibacterial |
Medical Subject Heading (MeSH) Categories for CEFTAZIDIME
Anatomical Therapeutic Chemical (ATC) Classes for CEFTAZIDIME
US Patents and Regulatory Information for CEFTAZIDIME
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acs Dobfar | CEFTAZIDIME | ceftazidime | INJECTABLE;INJECTION | 062640-002 | Nov 20, 1985 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Aurobindo Pharma Ltd | CEFTAZIDIME | ceftazidime | INJECTABLE;INJECTION | 065482-001 | May 28, 2010 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Acs Dobfar | CEFTAZIDIME | ceftazidime | INJECTABLE;INJECTION | 062640-001 | Nov 20, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Baxter Hlthcare | CEFTAZIDIME SODIUM IN PLASTIC CONTAINER | ceftazidime sodium | INJECTABLE;INJECTION | 063221-001 | Apr 29, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Aurobindo Pharma Ltd | CEFTAZIDIME | ceftazidime | INJECTABLE;INJECTION | 065481-001 | May 28, 2010 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Baxter Hlthcare | CEFTAZIDIME SODIUM IN PLASTIC CONTAINER | ceftazidime sodium | INJECTABLE;INJECTION | 063221-003 | Apr 29, 1993 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Acs Dobfar | CEFTAZIDIME | ceftazidime | INJECTABLE;INJECTION | 062640-003 | Nov 20, 1985 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
